Proactive vs reactive therapeutic drug monitoring in Inflammatory Bowel Disease (IBD)
Biohit Healthcare Ltd
This webinar will brought together Jimmy Limdi – Consultant Gastroenterologist and Head of the Section for IBD at the Northern Care Alliance NHS Foundation Trust – and Christian Selinger – Consultant Gastroenterologist at Leeds Teaching Hospitals NHS Trust – to discuss proactive versus reactive therapeutic drug monitoring (TDM) for inflammatory bowel disease (IBD). The main discussion was moderated by The Clinical Services Journal, where the two speakers deliberated about the benefits and limitations of using proactive and reactive TDM, with details of their trusts’ practices and case studies.
A live Q&A was held after where attendees could raise any questions.
- Date
- Duration
- Recording
